MAP4K5 expression based on
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison | Statistical significance |
Normal-vs-Primary | 1.30995214675522E-12 |
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
3.63109997625344E-09 |
Normal-vs-Stage2 |
6.644200E-03 |
Normal-vs-Stage3 |
N/A |
Normal-vs-Stage4 |
5.383700E-03 |
Stage1-vs-Stage2 |
3.625400E-01 |
Stage1-vs-Stage3 |
N/A |
Stage1-vs-Stage4 |
8.403000E-01 |
Stage2-vs-Stage3 |
N/A |
Stage2-vs-Stage4 |
4.831200E-01 |
Stage3-vs-Stage4 |
N/A |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
4.68860505975499E-11 |
Normal-vs-AfricanAmerican |
1.348980E-01 |
Normal-vs-Asian |
2.051600E-01 |
Caucasian-vs-AfricanAmerican |
8.113600E-01 |
Caucasian-vs-Asian |
9.961600E-01 |
AfricanAmerican-vs-Asian |
8.997000E-01 |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
3.62160000000333E-05 |
Normal-vs-Female |
2.14359999750613E-08 |
Male-vs-Female |
4.593800E-01 |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient BMI information is not available for 1 sample.
Descriptions |
Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Normal_Weight |
1.384470E-02 |
Normal-vs-Extreme_Weight |
1.68590000004798E-06 |
Normal-vs-Obese |
1.203050E-04 |
Normal-vs-Extreme_Obese |
N/A |
Normal_Weight-vs-Extreme_Weight |
1.748400E-01 |
Normal_Weight-vs-Obese |
1.542840E-01 |
Normal_Weight-vs-Extreme_Obese |
N/A |
Extreme_Weight-vs-Obese |
8.350600E-01 |
Extreme_Weight-vs-Extreme_Obese |
N/A |
Obese-vs-Extreme_Obese |
N/A |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
1.462810E-01 |
Normal-vs-Age(41-60Yrs) |
5.612900E-04 |
Normal-vs-Age(61-80Yrs) |
1.61950000077127E-08 |
Normal-vs-Age(81-100Yrs) |
4.042000E-01 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.716400E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.639200E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.102000E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.494800E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.077600E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.483810E-01 |
|
|
CHOL : Cholangiocarcinoma
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
N/A |
Normal-vs-Grade 2 |
3.768400E-01 |
Normal-vs-Grade 3 |
1.726360E-01 |
Normal-vs-Grade 4 |
1.000000E+00 |
Grade 1-vs-Grade 2 |
N/A |
Grade 1-vs-Grade 3 |
N/A |
Grade 1-vs-Grade 4 |
N/A |
Grade 2-vs-Grade 3 |
2.929800E-01 |
Grade 2-vs-Grade 4 |
3.768400E-01 |
Grade 3-vs-Grade 4 |
1.726360E-01 |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 5 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
8.24290002920947E-09 |
Normal-vs-N1 |
2.616700E-03 |
N0-vs-N1 |
1.532980E-01 |
|
|